Nanoscope Therapeutics to Participate in Eyecelerator 2026 and the American Academy of Ophthalmology 2026 Annual Meeting
<p>Chief Medical Officer Dr. Sam Barone to join the Emerging Innovations in Retinal Therapies panel; Company to present an update on MOGENRY® in the Retina Drug Delivery & New Targets Showcase at Eyecelerator 2026 Four-year REMAIN data from the RESTORE Phase 2b/3 trial of MCO-010 in...</p>
Read original article ↗
Related Articles
Municipal Bond Market Faces Generational Shift as Retail Investor Participation Grows
BAM Mutual launches new effort to engage next generation of financial advisors and investors around municipal credit NEW
Planon Launches Field Services Solution in North America to Unite Facilities and Field Operations
New solution helps service providers and distributed organizations connect buildings, technicians and customers on one p
Robin is building a platform for agentic AI that plans, coordinates and resolves work within the boundaries customers se
Robin Reinvents Space Planning for the Workplace, Claude-First
Workplace teams can build stack plans, update seating and model growth through a conversation, working from their own fl